Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment

[1]  C. von Buchwald,et al.  Genetic susceptibility to angiotensin-converting enzyme-inhibitor induced angioedema: A systematic review and evaluation of methodological approaches , 2019, PloS one.

[2]  M. Kennedy,et al.  Pharmacogenetics of angiotensin‐converting enzyme inhibitor‐induced angioedema , 2018, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[3]  M. Kuruvilla,et al.  Amlodipine-induced angioedema: An unusual complication of a common medication , 2018, Allergy & rhinology.

[4]  R. Lockey,et al.  The international WAO/EAACI guideline for the management of hereditary angioedema—The 2017 revision and update , 2018, Allergy.

[5]  Edward D McCoul,et al.  Pharmacotherapy for Angiotensin-Converting Enzyme Inhibitor–Induced Angioedema: A Systematic Review , 2018, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[6]  M. V. Van Berkel,et al.  Novel Therapies for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Systematic Review of Current Evidence. , 2017, The Journal of emergency medicine.

[7]  J. Pesquero,et al.  A rare mutation in the F12 gene in a patient with ACE inhibitor-induced angioedema. , 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[8]  Kenneth H. Lai,et al.  Epidemiology of ACE Inhibitor Angioedema Utilizing a Large Electronic Health Record. , 2017, Journal of Allergy and Clinical Immunology: In Practice.

[9]  P. Hallberg,et al.  Comparison of Clinical Factors Between Patients With Angiotensin-Converting Enzyme Inhibitor–Induced Angioedema and Cough , 2017, The Annals of pharmacotherapy.

[10]  M. Baş.  The Angiotensin-Converting-Enzyme-Induced Angioedema. , 2017, Immunology and allergy clinics of North America.

[11]  C. Wadelius,et al.  Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish population. , 2017, Pharmacogenomics.

[12]  C. Palmer,et al.  Effect of Serotonin Transporter 5-HTTLPR Polymorphism on Gastrointestinal Intolerance to Metformin: A GoDARTS Study , 2016, Diabetes Care.

[13]  Mitchell J. Machiela,et al.  LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants , 2015, Bioinform..

[14]  G. Kojda,et al.  Angioedema induced by cardiovascular drugs: new players join old friends , 2015, Allergy.

[15]  J G Linneman,et al.  A genome-wide association study identifies variants in KCNIP4 associated with ACE inhibitor-induced cough , 2015, The Pharmacogenomics Journal.

[16]  Michael Q. Zhang,et al.  Integrative analysis of 111 reference human epigenomes , 2015, Nature.

[17]  D. Beezhold,et al.  Examination of genetic variants involved in generation and biodisposition of kinins in patients with angioedema , 2014, Allergy, Asthma & Clinical Immunology.

[18]  F. Poulsen,et al.  Perindopril and residual chronic subdural hematoma volumes six weeks after burr hole surgery: A randomized trial , 2014, Clinical Neurology and Neurosurgery.

[19]  Andrew D. Johnson,et al.  Gene-age interactions in blood pressure regulation: a large-scale investigation with the CHARGE, Global BPgen, and ICBP Consortia. , 2014, American journal of human genetics.

[20]  M. Pirmohamed,et al.  Phenotype Standardization of Angioedema in the Head and Neck Region Caused by Agents Acting on the Angiotensin System , 2014, Clinical pharmacology and therapeutics.

[21]  A. Bygum,et al.  Angiotensin-converting enzyme inhibitor-induced angioedema--a dangerous new epidemic. , 2014, Acta dermato-venereologica.

[22]  Shaun M. Purcell,et al.  Statistical power and significance testing in large-scale genetic studies , 2014, Nature Reviews Genetics.

[23]  Manolis Kellis,et al.  Systematic discovery and characterization of regulatory motifs in ENCODE TF binding experiments , 2013, Nucleic acids research.

[24]  G. Vilke,et al.  Emergency department management of patients with ACE-inhibitor angioedema. , 2013, The Journal of emergency medicine.

[25]  James Brian Byrd,et al.  Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema , 2013, Pharmacogenetics and genomics.

[26]  Shannon W Finks,et al.  Life-Threatening ACE Inhibitor-Induced Angioedema After Eleven Years on Lisinopril , 2013, Journal of pharmacy practice.

[27]  E. Sturrock,et al.  Association of B2 Receptor Polymorphisms and ACE Activity With ACE Inhibitor–Induced Angioedema in Black and Mixed‐Race South Africans , 2013, Journal of clinical hypertension.

[28]  J. Sheikh,et al.  A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema. , 2013, The Journal of allergy and clinical immunology.

[29]  M. Johannesson,et al.  The Swedish Twin Registry: Establishment of a Biobank and Other Recent Developments , 2012, Twin Research and Human Genetics.

[30]  Raymond K. Auerbach,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[31]  Manolis Kellis,et al.  HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..

[32]  N. Hooper,et al.  A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor‐induced angioedema , 2011, Human mutation.

[33]  J. Ludvigsson,et al.  External review and validation of the Swedish national inpatient register , 2011, BMC public health.

[34]  F. Messerli,et al.  Visceral angioedema due to angiotensin-converting enzyme inhibitor therapy , 2011, Cleveland Clinic Journal of Medicine.

[35]  James Brian Byrd,et al.  Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema , 2010, Pharmacogenetics and genomics.

[36]  B. Stricker,et al.  Pharmacogenetic interactions between ABCB1 and SLCO1B1 tagging SNPs and the effectiveness of statins in the prevention of myocardial infarction. , 2010, Pharmacogenomics.

[37]  Wolfgang Viechtbauer,et al.  Conducting Meta-Analyses in R with the metafor Package , 2010 .

[38]  R. Köhler.  Single-nucleotide polymorphisms in vascular Ca2+-activated K+-channel genes and cardiovascular disease , 2010, Pflügers Archiv - European Journal of Physiology.

[39]  M. Vingron,et al.  Quantifying the effect of sequence variation on regulatory interactions , 2010, Human mutation.

[40]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[41]  J. Jordan.  Sluggish genes and hypertension. , 2008, Journal of hypertension.

[42]  Isaac Subirana,et al.  Genetic variation in the KCNMA1 potassium channel α subunit as risk factor for severe essential hypertension and myocardial infarction , 2008, Journal of hypertension.

[43]  A. Devaiah,et al.  Angioedema and angiotensin-converting enzyme inhibitors: Are demographics a risk? , 2008, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[44]  Donald R. Miller,et al.  Angioedema Incidence in US Veterans Initiating Angiotensin-Converting Enzyme Inhibitors , 2008, Hypertension.

[45]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[46]  G. Kojda,et al.  Nonallergic angioedema: role of bradykinin , 2007, Allergy.

[47]  B. Davis,et al.  Incidence and Predictors of Angioedema in Elderly Hypertensive Patients at High Risk for Cardiovascular Disease: A Report From the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) , 2006, Journal of clinical hypertension.

[48]  J. Rouleau,et al.  A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. , 2005, American journal of human genetics.

[49]  T. Casale,et al.  Incidence and characteristics of angioedema associated with enalapril. , 2005, Archives of internal medicine.

[50]  J. Storm,et al.  Elevated Blood Pressure Linked to Primary Hyperaldosteronism and Impaired Vasodilation in BK Channel–Deficient Mice , 2005, Circulation.

[51]  H. Krum,et al.  Losartan Increases Bradykinin Levels in Hypertensive Humans , 2005, Circulation.

[52]  H. Black,et al.  Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial. , 2004, American journal of hypertension.

[53]  Karl Swedberg,et al.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.

[54]  W A Ray,et al.  Black Americans have an increased rate of angiotensin converting enzyme inhibitor‐associated angioedema , 1996, Clinical pharmacology and therapeutics.

[55]  O. Delaneau,et al.  Supplementary Information for ‘ Improved whole chromosome phasing for disease and population genetic studies ’ , 2012 .

[56]  K. Lahiri,et al.  Amiodarone-induced angioedema: report of two cases. , 2005, Indian journal of dermatology, venereology and leprology.

[57]  Pak Chung Sham,et al.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits , 2003, Bioinform..

[58]  Claus Rydahl Torp,et al.  [Where is the National Board of Health and Welfare?]. , 2003, Ugeskrift for laeger.

[59]  T. Unger,et al.  AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. , 1998, Hypertension.